Back
Lonza Group Vs. CRISPR Therapeutics AG Industry Stock Comparison
Sell
39
LZAGF
Lonza Group
Last Price:
603.15
Seasonality Move:
8.49%
Sell
44
CRSP
CRISPR Therapeutics AG
Last Price:
43.82
Seasonality Move:
19.76%
Sell
39
Lonza Group (LZAGF)
is a Sell
Is Lonza Group a Buy, Sell or Hold?
- The current Lonza Group [LZAGF] share price is $603.15. The Score for LZAGF is 39, which is 22% below its historic median score of 50, and infers higher risk than normal.
- LZAGF is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
44
CRISPR Therapeutics AG (CRSP)
is a Sell
Is CRISPR Therapeutics AG a Buy, Sell or Hold?
- The current CRISPR Therapeutics AG [CRSP] share price is $43.78. The Score for CRSP is 44, which is 12% below its historic median score of 50, and infers higher risk than normal.
- CRSP is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
LZAGF Stock Price Chart
What is Lonza Group's stock price today?
-
The Lonza Group share price today is $603.15
The current trend is relatively stagnant and LZAGF is experiencing slight buying pressure.
CRSP Stock Price Chart
What is CRISPR Therapeutics AG's stock price today?
-
The CRISPR Therapeutics AG share price today is $43.78
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and CRSP is experiencing slight selling pressure.
LZAGF Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -4.35 | Sell |
Relative Strength Index (14 RSI): | 51.26 | Buy |
Chaikin Money Flow: | 23 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (578.41 - 616.21) | Buy |
Bollinger Bands (100): | (599.67 - 653.11) | Sell |
CRSP Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.57 | Sell |
Relative Strength Index (14 RSI): | 37.78 | Sell |
Chaikin Money Flow: | -817353 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (46.65 - 52.01) | Sell |
Bollinger Bands (100): | (45.63 - 51.81) | Sell |
LZAGF Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 591.26 | Buy |
20-day SMA: | 590.15 | Buy |
50-day SMA: | 608.43 | Sell |
200-day SMA: | 594.33 | Buy |
8-day EMA: | 594.58 | Buy |
20-day EMA: | 596.37 | Buy |
50-day EMA: | 606 | Sell |
200-day EMA: | 588.84 | Buy |
CRSP Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 48.56 | Sell |
20-day SMA: | 48.98 | Sell |
50-day SMA: | 48.62 | Sell |
200-day SMA: | 54.99 | Sell |
8-day EMA: | 47.66 | Sell |
20-day EMA: | 48.82 | Sell |
50-day EMA: | 48.97 | Sell |
200-day EMA: | 52.8 | Sell |
Lonza Group Earnings Growth & LZAGF Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
CRISPR Therapeutics AG Earnings Growth & CRSP Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.16 per share, a decrease next quarter of $0.00 per share, a decrease this year of $2.19 per share, and an increase next year of $0.13 per share.
Lonza Group Technical Analysis
Dec 2 | Dec 3 | Dec 4 | Dec 5 | Dec 6 | Dec 9 | Dec 10 | Dec 11 | Dec 12 | Dec 13 | |
---|---|---|---|---|---|---|---|---|---|---|
Dec | ||||||||||
02 | 03 | 04 | 05 | 06 | 09 | 10 | 11 | 12 | 13 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
CRISPR Therapeutics AG Technical Analysis
Dec 2 | Dec 3 | Dec 4 | Dec 5 | Dec 6 | Dec 9 | Dec 10 | Dec 11 | Dec 12 | Dec 13 | |
---|---|---|---|---|---|---|---|---|---|---|
Dec | ||||||||||
02 | 03 | 04 | 05 | 06 | 09 | 10 | 11 | 12 | 13 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |